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Abstract 
 
Supraglottic airway devices have been used as safe alternatives to endotracheal intubation in appropriate types of 
surgery. This was a prospective, randomised, single blind study comparing the use of LMA™ and SLIPA™ in terms 
of ease of insertion, haemodynamic changes and occurrence of adverse effects (e.g. blood stains on the device upon 
removal and sore throat). A total of 62 ASA I or II patients, aged between 18 to 70 years were recruited for this 
study. Patients were randomised into two groups; LMA™ and SLIPA™ group. Following induction of anaesthesia, 
an appropriate sized LMA™ or SLIPA™ was inserted after ensuring adequate depth of anaesthesia. Anaesthesia was 
maintained with oxygen, nitrous oxide and sevoflurane. The ease of insertion was graded and haemodynamic 
changes were recorded at 2 minute intervals up to 10 minutes after insertion of the airway devices. The presence of 
blood stains upon airway device removal at the end of surgery and incidence of sore throat was also recorded. No 
difficult insertion was experienced in either of these devices. Insertion was either easy [LMA™ 87.1% versus 
SLIPA™ 80.6% (p = 0.49)] or moderate [LMA™ 12.9% versus SLIPA™ 19.4% (p = 0.16)]. Throughout the study 
period, the haemodynamic changes that occurred in both groups were not statistically different. Traces of blood were 
noted on the surface of the device in 9.7% of patients in the SLIPA™ group versus 6.5% of patients in the LMA™ 
group. The incidence of sore throat was recorded in 12.9% versus 19.4% of patients in the SLIPA™ and the LMA™ 
groups respectively. These findings were not statistically significant. In conclusion, this study showed no significant 
differences between the use of LMA™ and SLIPA™ in terms of ease of insertion, haemodynamic changes and 
adverse effects in patients undergoing minor surgical procedures. 
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Introduction 
 
The laryngeal mask airway (LMA™) was first 
introduced in United Kingdom in 1988 and in United 
States of America in 1992 as an alternative to the face 
masks (1).  It has been used in most elective and 
outpatient surgical procedures. It has since been 
recognised as a valuable rescue airway tool in both 
adult and paediatric resuscitation especially when 
managing a difficult airway. It is a relatively 
expensive device designed for multiple uses and as 
such requires time consuming maintenance 
procedures such as cleaning and autoclaving. The risk 
of cross-infection still remains despite cleaning and 
autoclaving of the airway device after use (2).  
 
The Streamlined Liner of Pharyngeal Airway, SLIPA 
Medical Ltd., UK (SLIPA™) made of soft plastic is 
designed for single use and has the potential to 
replace the LMA™ (3).  It is a hollow, preformed, 
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boot-shaped airway which anatomically engages in 
the pharynx and palate (4). The SLIPA™ is designed 
without an inflatable cuff as its shape resembles the 
anatomy of the pharynx closely (5).  The risk of 
pulmonary aspiration is reduced by the presence of a 
50 ml empty internal space within the device which 
allows removal of pharyngeal secretions (3). Insertion 
of the device can be done without the assistance of 
other devices and it is relatively cheaper than the 
LMA™ (6, 7). In Europe in 2008, the estimated cost 
of  a single use LMA™ and SLIPA™ was about £80 
(MYR520) and £2.80 (MYR18.20), respectively (7). 
 
Many clinical studies and researches have been 
conducted on various supraglottic airway devices in 
the United States of America, United Kingdom, 
Europe, Australia, India, Korea, Japan and Saudi 
Arabia to assess their clinical uses, efficacy and safety 
for both anaesthetic as well as emergency airway 
management (4, 7-13). They concluded that the ease 
of insertion, haemodynamic changes, seal pressure, 
and gastric insufflation were comparable for both 
SLIPA™ and LMA™ supraglottic airway devices (9-
11).  
 
Over the past five years, the number of countries 
using the SLIPA™ has grown dramatically. This is 
due to its simplicity and ease of use. The use of 
SLIPA™ in Malaysia is still relatively new as it is not 
readily available in the country. Therefore, there is 
lack of familiarity of the device amongst Malaysian 
health care providers. So far, there are no studies 
published locally on its usage and efficacy.  
 
This study was conducted to compare the use of 
LMA™ and SLIPA™ in terms of ease of insertion, 
haemodynamic changes and occurrence of adverse 
effects (traces of blood on the airway device upon 
removal and sore throat after surgery) in patients 
undergoing minor surgical procedures.  
 
Materials and Methods 
 
This was a prospective, randomised, single blind 
study. Following institutional ethics committee 
approval and obtaining informed consent, 62 patients 
were recruited with American Society of 
Anaesthesiologists (ASA) physical status I or II aged 
between 18 to 70 years who were scheduled for 
elective minor Orthopaedic, Gynaecological and 
General Surgical procedures under general 
anaesthesia in which the anticipated duration of 
surgery was less than two hours. Patients excluded 
were those with risk of pulmonary aspiration, morbid 
obesity (body mass index > 35 kg/m2), pregnancy, 
history of gastro-oesophageal reflux, hiatus hernia, 
potential airway difficulty, pre-operative upper 
respiratory tract infection in the last 2 weeks and 
procedures involving the airway.   Patients were 
fasted for at least 6 hours prior to surgery. Oral 
midazolam 3.75 - 7.5 mg, depending on age and 
weight of the patient, was given as night sedation as 
well as premedication prior to sending patients to the 
operation theatre. All device insertions were 
performed by a single investigator who had at least 5 
years experience in using the LMA™ and had used 
the SLIPA™  at least 10 times before the study was 
initiated. Postoperative assessment was carried out by 
blinded independent observers in the recovery bay. 
 
Patients were allocated using computer generated 
randomised numbers to one of two groups, the 
LMA™ group and SLIPA™ group. The appropriate 
size of the LMA™ was chosen according to standard 
practice i.e. according to body weight (size range 
from 3-5), whereas the size of SLIPA™ was chosen 
by matching the gender and height of the patient with 
the predetermined size from the manufacturer’s guide 
(size range from 47-57). Water-based lubricant (K-Y 
jelly) was used for both devices. Standard monitoring 
for all patients included the electrocardiograph, non-
invasive blood pressure monitor, pulse oximeter and 
capnograph. Pre-oxygenation was done with 100% 
oxygen for 3 minutes after which patients were 
induced with fentanyl (2 mcg/kg), propofol (2-3 
mg/kg) and deepened with sevoflurane. Patients were 
not paralysed in this study. The respective 
supraglottic airway device was introduced into the 
pharynx after adequate anaesthetic depth had been 
achieved and this was confirmed by clinical 
assessment and on reaching a minimal alveolar 
concentration (MAC) value of 1. If the LMA™ was 
used, the cuff was inflated according to the 
manufacturer’s guideline (1) after successful 
placement. Successful placement of the airway 
device, was verified by sufficient ventilation (8-10 
ml/kg), SpO2 > 95% and normal readings (35-45 
mmHg) on the capnograph.  Another 10 ml of air was 
added if substantial leakage occurred despite optimal 
placement of the LMA™.  If the SLIPA™ was 
selected, a similar technique as the LMA™ was used 
for insertion into the pharynx. Following correct 
placement, patients were connected to a breathing 
circuit and initially given assisted ventilation. 
Subsequently, patients were allowed to breath 
spontaneously throughout the duration of anaesthesia. 
 
Ease of insertion was rated as “easy”, if successful 
placement was made at the first attempt within 15 
seconds. If the first attempt was unsuccessful, mask
Comparing airway devices: LMA™ vs SLIPA™                                                                                                  Abd Rahman I et al. 
10 
 
Table 1: Demographic data, values expressed as mean ± SD or numbers where appropriate. 
 
 Group LMA™ (n=31) 
Group SLIPA™ 
(n=31) 
Age (years) 43.8  ± 15.5 46.0  ± 15.9 
   
Height (m) 157.1  ± 4.5 158.2  ± 3.9 
   
Weight (kg) 58.2  ± 5.5 60.1  ± 5.6 
   
BMI (kg/m2)  23.5  ± 1.5 24.0  ± 1.7 
   
Gender: Male/Female 13/18 15/16 
   
ASA: I/II 17/14 21/10 
   
Race: Malay/Chinese/Indian  14/12/5 15/13/3 
 
ventilation was resumed and adequate anaesthetic 
depth re-established before subsequent attempts. 
Subsequently, ease of insertion was rated as 
“moderate” with successful placement at the second 
attempt; “difficult” with successful placement at the 
third attempt. If the third attempt failed, it would be 
rated as “impossible”; patients would then be 
intubated and excluded from the study. Anaesthesia 
was maintained with a mixture of oxygen and nitrous 
oxide (50% / 50%) at a flow rate of 2 L/min and 1-2% 
sevoflurane to maintain a MAC of 1. The 
haemodynamic parameters [heart rate (HR), systolic 
(SBP), diastolic (DBP) and mean arterial pressure 
(MAP)] were recorded at pre-induction and at 2 
minute intervals for the first 10 minutes after insertion 
of the supraglottic devices.  
 
At the end of the operation, the airway device was 
removed when spontaneous tidal volume reached a 
minimum of 8 ml/kg and the patient responded to 
verbal command. Upon removal, the airway device 
was inspected for traces of blood on its surface. Thirty 
minutes after arrival in the recovery bay, patients 
were interviewed by independent observers to 
determine whether they had a sore throat. A visual 
analog scale (VAS) from 0-10 was used to rate the 
severity of the sore throat [score of 1-3 (mild); 4-5 
(moderate) and > 5 (severe sore throat)].  
 
Sample size in this study was chosen based on similar 
studies done earlier (3, 7).The α value was determined 
at 0.05 and power of study at 80%. Using the power 
and sample size calculator, PS2, a sample size of 26 
in each arm was obtained. Allowing for a 20% drop 
out rate, the total sample size determined was 62.   
Table 2: Ease of insertion of both devices, values 
expressed in number (percentage). 
 
 LMA™ 
(n=31) 
SLIPA™ 
(n=31) p value 
Easy 27 (87.1) 25 (80.6) 0.49 
Moderate 4 (12.9) 6 (19.4) 0.16 
Difficult 0 0  
Impossible 0 0  
Success rate 100% 100%  
 
Data analysis was done using SPSS 13 for 
WINDOWS (LEAD Technologies, Inc. USA). 
Student’s t-test was used to analyse demographic data 
such as age, weight, height, body mass index (BMI), 
gender and ASA group. Qualitative data such as ease 
of insertion, heart rate, blood pressure, presence of 
blood on the airway device and sore throat was 
analysed by the Chi-square test. Analysis of variance 
(ANOVA) was used to compare blood pressure, 
oxygen saturation and heart rates between both 
groups. Statistical significance was considered with a  
p value of < 0.05. 
 
Results 
 
A total of 62 patients who underwent elective minor 
surgery under general anaesthesia were studied and 
randomly assigned into 2 groups. Thirty one patients 
received the LMA™ while another thirty one received 
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SLIPA™ as an airway device during general 
anaesthesia. Both groups were comparable in terms of 
demographic data as illustrated in Table I.  
 
There was no significant statistical difference 
experienced between the two devices in terms of ease 
of insertion as shown in Table II.  
 
Throughout the study period, no significant 
differences were detected between pre-induction and 
post-induction haemodynamic changes (heart rate, 
systolic, diastolic and mean arterial pressure) in both 
groups as shown in Figure 1, Figure 2, Figure 3 and 
Figure 4. .  
 
Traces of blood were noted on the surface of the 
device in 6.5% (n=2) versus 9.7% (n=3) in the 
LMA™ and the SLIPA™ groups, respectively. Sore 
throat was complained in 19.4% (n=6) of the LMA™ 
group versus 12.9% (n=4) in the SLIPA™ group. 
Only mild sore throat (VAS 1-3) was reported in all 
patients that complained of this adverse effect. 
However, these incidences of adverse effects were 
found not to be statistical significant in both groups. 
 
Discussion 
 
In our study, placement of the device was easy in 27 
patients (87.1%) in the LMA™ group and in 25 
patients (80.6%) in the SLIPA™ group. All second 
attempts on placement of the device were successful 
in both groups. First insertion success rates have been 
reported to range between 73.3% - 98% in inserting 
the SLIPA™ versus 90% - 100% for the LMA™ 
among experienced anesthetists in previous studies (3, 
4, 10, 13). Meanwhile, a study conducted on medical 
students with no experience on SLIPA™ or LMA™ 
demonstrated that the first insertion success rate was 
83% and 67% with an overall success rate 94% and 
89% for SLIPA™ and the SoftSeal Laryngeal Mask, 
respectively (14). The variation in the results may be 
due to the relative experience of the anesthesiologist 
who inserted the airway and the appropriate size of 
the SLIPA™ chosen. For a successful insertion, 
correct size selection is important because SLIPA™ 
comes in a fixed preformed shape and six adult sizes 
(47-57). SLIPA™ size was selected in previous 
studies by matching the patient's thyroid cartilage 
with the transverse diameter of the device (3, 7, 8, 
10). In this study, we followed the size selection 
guideline which involved gender and height as 
recommended by the SLIPA™ manufacturer. 
However the range of size selection can be too wide 
and often found to be overlapping. Selecting the right 
size on the first attempt can be difficult. The 
development of guidelines for SLIPA™ size selection 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Changes in heart rate (HR) at different time 
intervals of both devices. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Systolic blood pressure (SBP) at different 
time intervals of both devices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Diastolic blood pressure (DBP) at different 
time intervals of both devices. 
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Figure 4: Mean arterial pressure (MAP) at different 
time intervals of both devices. 
 
amongst the Asian population is therefore 
recommended.  
 
One benefit of using a supraglottic airway device is 
that it does not require the use of a laryngoscope 
during insertion, thus avoiding direct stimulation of 
the larynx and trachea. During endotracheal 
intubation, a brief temporary increase of heart rate 
and blood pressure with possibility of developing 
arrhythmias may occur caused by stimulation to the 
upper airway caused by the laryngoscope blade, to the 
tracheal intubation itself and cuff inflation of the 
endotracheal tube (12). In this study, there was no 
significant difference between the two groups in 
terms of haemodynamic changes (HR, SBP, DBP and 
MAP) after insertion of the device.  Interestingly, a 
study has reported that with SLIPA™ use, blood 
pressure and heart rate increased more compared to 
the LMA™ (7), but this difference was not as marked 
as that observed between endotracheal intubation and 
LMA™  insertion (12). We postulate that a reduction 
in insertion time and a more stable haemodynamic 
response may be achieved with the correct SLIPA™ 
size selection and insertion technique.  
 
In this study, patients in the SLIPA™ group had a 
slightly higher incidence of blood stains (9.7%) 
compared to those in the LMA™ (6.5%) group after 
removal of the airway devices, however this was not 
statistically significant. Reinsertion of SLIPA™ was 
associated with blood stained devices in all 3 patients, 
suggesting that SLIPA™ has the potential to cause 
more trauma with more than one insertion attempt. 
Incidence of blood traces on the SLIPA device has 
been found to range between 20% - 40% in previous 
studies as compared to 11% - 22% in the LMA group 
(4, 10, 15). The SLIPA™ device is made of stiffer 
plastic material than the LMA™, which causes more 
direct trauma to the oral mucosa. The following 
manoeuvres have been suggested to help improve on 
ease of insertion and to reduce trauma: assisted 
insertion by an assistant holding up the jaw or by 
creatng a more suitable space in the pharynx with the 
use of a laryngoscope or  by using a gloved left thumb 
with either the middle or index finger (3).     
 
In our study, the incidence of sore throat was lower in 
the SLIPA™ (12.9%) group compared with the 
LMA™ (19.4%) group, however this was not found 
to be statistically significant. We did not standardise 
other factors such as intraoperative analgesia used for 
example intravenous morphine or parecoxib which 
may reduce the incidence of sore throat 
postoperatively. Sore throat assessed by the VAS 
score may also be very subjective. Similarly, another 
study (10) also reported fewer patients in the 
SLIPA™ group (2%) who complained of sore throat 
compared with those in LMA™ group (14%). This 
higher incidence of sore throat in the LMA™ group 
could be due to the inflatable cuff of the LMA™ 
exerting pressure on the pharynx. Even so, in most 
studies conducted, the use of SLIPA™ was associated 
with a higher incidence of sore throat which could be 
attributable to its stiff material which could irritate 
and damage the pharyngeal mucosa (4). 
 
There were a few limitations in our study. As it was 
impossible to ‘blind’ the primary investigator who 
inserted the airway devices, the potential for bias 
exists. Maximum airway sealing pressures were not 
measured comparing both devices to evaluate which 
device provided higher airway sealing pressures. 
Theoretically, supraglottic airway devices with higher 
sealing pressures should be able to protect the airway 
from aspiration better than those with low sealing 
pressures. In this study, we did not insert a fibreoptic 
bronchoscope through the airway port to evaluate the 
glottic view to assess appropriate placement of the 
airway devices. Lastly, as we excluded obese patients 
and those with a difficult airway, the results cannot be 
extrapolated to this group of patients. 
 
In conclusion, this study showed no significant 
differences between the use of LMA™ and SLIPA™ 
in terms of ease of insertion, haemodynamic changes 
and adverse effects (traces of blood on the airway 
device and sore throat) in patients undergoing minor 
surgical procedures. 
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